1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,460 | 6,020 | 14:34 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.08. | Paxman: Quartalsumsatz übertrifft erstmals 100 Mio. SEK - Aktie legt um 15 % zu | 1 | Investing.com Deutsch | ||
| 21.08. | Paxman Aktie steigt um 15 % nach Rekordumsatz im zweiten Quartal 2026, der erstmals 100 Mio. SEK übersteigt | 1 | Investing.com Deutsch | ||
| 21.08. | Paxman AB: PAXMAN publishes its interim report for Q2 2026 | 289 | GlobeNewswire (Europe) | Paxman breaks the 100 MSEK barrier for the first time in a record-breaking Q2!
Figures in parentheses refer to the outcome for the corresponding period of the previous year. Dignitana has been part... ► Artikel lesen | |
| 10.08. | Paxman AB: Paxman Announces FDA Regulatory Progress for Limb Cryocompression System | 230 | GlobeNewswire (Europe) | Paxman today announces a significant regulatory milestone in the development of its Limb Cryocompression System for the reduction of chemotherapy-induced peripheral neuropathy (CIPN), with the U.S.... ► Artikel lesen | |
| 22.05. | Paxman AB: Press release from PAXMAN AB's 2026 Annual General Meeting | 428 | GlobeNewswire (Europe) | PAXMAN's AGM was held today, 22 May 2026, in Karlshamn. Almost 36,4 % of all issued shares were represented at the meeting. After the formal AGM, CEO Richard Paxman gave a digital company presentation... ► Artikel lesen | |
| 21.05. | Paxman AB: PAXMAN publishes its interim report for Q1 2026 | 281 | GlobeNewswire (Europe) | Figures in parentheses refer to the outcome for the corresponding period of the previous year. Dignitana has been part of the group since June 1 2025.
The Group's sales amounted to 89.6 (67.1) MSEK... ► Artikel lesen | |
| 27.02. | Paxman AB: PAXMAN publishes year-end report as of 31 December 2025 | 948 | GlobeNewswire (Europe) | Strategic investments support future growth!
Figures in parentheses refer to the outcome for the corresponding period of the previous year.The Group's net sales amounted to 84.4 (66.2) MSEK for the... ► Artikel lesen | |
| 20.02. | Paxman AB: Paxman Announces Category III CPT Codes for Cryocompression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy | 841 | GlobeNewswire (Europe) | Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III CPT® codes describing the... ► Artikel lesen | |
| PAXMAN Aktie jetzt für 0€ handeln | |||||
| 14.11.25 | Paxman AB: PAXMAN publishes its interim report for Q3 2025 | 486 | GlobeNewswire (Europe) | First full post acquisition quarter builds momentum for 2026
(Dignitana has been part of the group since June 1. Figures in parentheses refer to the outcome for the corresponding period of the previous... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,760 | 0,00 % | ANALYSE-FLASH: RBC hebt Ziel für Siemens Healthineers auf 48 Euro - 'Outperform' | NEW YORK (dpa-AFX Broker) - Die kanadische Bank RBC hat das Kursziel für Siemens Healthineers von 45 auf 48 Euro angehoben und die Einstufung auf "Outperform" belassen. Der Start des neuen Strahlentherapiesystems... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,86 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 45,495 | +0,42 % | Fresenius: Mahl übernimmt Kabi - Hennicken bleibt bis 2032 | Marc-Alexander Mahl zieht zum 1. November 2026 in den Vorstand von Fresenius ein und übernimmt dort die Verantwortung für Fresenius Kabi. Der 58-Jährige folgt auf Pierluigi Antonelli, der den Konzern... ► Artikel lesen | |
| HEARTFLOW | 55,44 | +0,01 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| FRESENIUS MEDICAL CARE | 39,960 | +1,99 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC nach Gesprächen mit dem Unternehmen mit einem Kursziel von 32,30 Euro auf "Underweight" belassen. Die Quartalszahlen des Dialysespezialisten... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,565 | +0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| CONCENTRA GROUP | 39,970 | 0,00 % | Stephens initiates Concentra stock with overweight on health model | ||
| PROGYNY | 29,120 | 0,00 % | Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report | ||
| AVEANNA HEALTHCARE | 13,310 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,010 | -0,10 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 28,310 | 0,00 % | Kestra Medical Technologies: Evercore-Einstufung treibt Aktie vorbörslich an | ||
| ALIGNMENT HEALTHCARE | 8,430 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors | ||
| GENEDX | 67,26 | 0,00 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| BILLIONTOONE | 105,67 | -0,01 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,890 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
Das Unternehmen PAXMAN AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,71 % bei einem Aktienkurs von 5,960 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PAXMAN AB finden Sie auf Wallstreet Online.